Core Viewpoint - Eimskipafélag Íslands hf. is set to release its second quarter 2025 results on August 26, 2025, after market closing [1] Group 1: Investor Meeting - An investor meeting is scheduled for August 27, 2025, where CEO Vilhelm Thorsteinsson and CFO Rósa Guðmundsdóttir will present the results [2] - The meeting will take place at the company's headquarters and will be webcasted live in Icelandic [2] - Investors are encouraged to send questions prior to the meeting via email [2] Group 2: Additional Information - Documents and a recording of the investor meeting will be accessible on the company's investor relations website [3] - For further inquiries, contact information for the Head of Treasury and Investor Relations is provided [3]

Core Viewpoint - Landsbankinn has successfully completed the sale of floating rate senior preferred bonds amounting to SEK 500 million with a three-year maturity [1] Group 1: Bond Details - The bonds were priced at a spread of 90 basis points over the 3-month STIBOR [1] - The issuance will be conducted under the bank's EMTN programme [1] - The bonds are expected to be admitted to trading on Euronext Dublin starting from 28 August 2025 [1] Group 2: Transaction Participants - SEB acted as a dealer in this transaction [1]

Company Overview - Ipsos has appointed Jean-Laurent Poitou as the new Chief Executive Officer, effective September 15, 2025, replacing Ben Page [2][10] - The company is one of the largest market research firms globally, operating in 90 markets and employing nearly 20,000 people [11] Market Dynamics - The market served by Ipsos is significant and dynamic, with strong demand from businesses and public institutions for timely and reliable data regarding their environments, markets, competitors, and performance [3] - There is an evolving demand for data that is produced securely and analyzed with precision, particularly in shorter timeframes, leveraging both human input and digital models [3] Strategic Positioning - The Board believes Ipsos is well-positioned to meet the evolving needs of its clients due to its scale, expertise, geographic coverage, and service diversity, aiming to regain a higher growth trajectory [4] - Ipsos intends to play an active role in transforming its industry by enhancing its capabilities for rapid data production, analysis, and reporting [7] Leadership Transition - The decision to appoint a new CEO aims to provide Ipsos with the momentum needed to adopt and implement a credible growth plan [5] - Jean-Laurent Poitou brings over 30 years of experience in digital transformation and artificial intelligence from his previous roles at Accenture and Alvarez & Marsal [6] Future Vision - Poitou expressed his commitment to leading Ipsos into its next growth chapter, leveraging the company's strong reputation, quality teams, and existing initiatives in technology and artificial intelligence [9] - The company aims to build a differentiated market research firm powered by science and technology while maintaining its core values [10]

Core Viewpoint - Tevogen Bio Holdings Inc. reported improved operational efficiency and reduced losses in its financial results for Q2 2025, indicating a positive trajectory towards anticipated revenue by the end of 2026 [1][2][3]. Financial Performance - For the three months ended June 30, 2025, the loss from operations was $5.4 million, a decrease from $8.6 million in the same period of 2024 [2][7]. - The net loss for the quarter was $5.5 million, compared to $9.7 million in Q2 2024, reflecting a significant improvement in financial performance [2][7]. Operational Strategy - The company is focused on maximizing capital efficiency and has access to sufficient financing to support its growth plans [3][7]. - Tevogen is in the process of establishing its own GMP manufacturing facility, which is a strategic move to enhance production control and accelerate product development timelines [4][7]. Market Position and Future Outlook - Tevogen acknowledges the limited growth in the market but emphasizes that it is building infrastructure, advancing AI, and strengthening internal capabilities [3][7]. - The company is exploring options to address its current limited tradable float to better meet investor demand [3][7].

SINGAPORE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Davis Commodities Limited (Nasdaq: DTCK), a Singapore-based agricultural trading company, today announced ongoing strategic reviews of tokenized yield instruments designed to extend the company’s initiatives in commodity finance digitization. The approach under study expands on Davis Commodities’ earlier assessments of Real Yield Tokenization (RYT), stablecoin settlement layers, and modular CFD structures, all aimed at connecting global agri-trade with programmab ...

SINGAPORE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Davis Commodities Limited (Nasdaq: DTCK), a Singapore-based agricultural trading company, announced today that it is reviewing the potential application of Real Yield Tokenization (RYT) as part of its broader strategy to digitize commodity finance and enhance ESG-aligned capital flows. RYT as a Potential On-Chain Yield Mechanism The RYT model, currently under preliminary assessment, could provide qualified market participants with a mechanism to potentially engag ...

COMPANY ANNOUNCEMENT No. 234/2025 Tvis, 19 August 2025 Interim report Q2 2025 (April 1 - June 30) (All figures in brackets refer to the corresponding period in 2024) Improved earnings and steady sales growth, delivered in a challenging market. CEO Torben Paulin:“Sales in the second quarter developed broadly in line with our expectations, with growth in both the B2B and B2C segments, following the solid order intake in the first quarter of 2025. Total sales for the quarter increased by 5% year-on-year to D ...

REGULATED INFORMATION Courbevoie, France – August 19, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights31/07/2025453,911,256 Theoretical number of voting rights: 584,208 961 Number of exercisable voting rights: 573,868,420 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January ...

COMPANY ANNOUNCEMENT No. 233/2025 Tvis, 19 August 2025 TCM Group A/S narrow full year expectations for 2025. Considering the results from the first six months of the year and the development in order intake during Q2, we are narrowing our guidance for 2025 both with regard to sales and earnings. TCM Group adjust the financial outlook for 2025 as follows: Full year revenue in the range of DKK 1,250–1,300 million (previously DKK 1,250 – 1,325 million), and Adjusted EBIT of DKK 90–110 million (previously DKK ...

Financial highlights Q2 2025 Revenues in Q2 2025 amounted to ISK 7,196 million, up from ISK 6,871 million Q2 2024, an increase of 4.7%. Revenue from mobile, data transmission, and television services grew by 2.5% year-on-year. Advertising revenues amounted to ISK 604 million compared with ISK 535 million in the same period last year, an increase of 12.9%.EBITDA amounted to ISK 1,924 million in Q2 2025, up by ISK 198 million or 11.5% from Q2 2024. EBITDA margin improved to 26.7% from 25.1% in the prior year. ...